Iterum Therapeutics Plc (ITRM) Misses Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Join SI Premium – FREE
Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.95), $0.23 worse than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- KB Home (KBH) PT Lowered to $50 at RBC Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
